✦ LIBER ✦

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A

✍ Scribed by Edward F. Ellerbeck; John A. Lewis; David Nalin; Kenneth Gershman; William J. Miller; Marcy E. Armstrong; Joseph P. Davide; Audrey E. Rhoad; Brenda McGuire; Gary Calandra; Philip J. Provost; Karen Midthun

Book ID: 119151206
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 561 KB
Volume: 10
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(92)90087-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a new formu

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

✍ Ron Dagan; David Greenberg; Polina Goldenbertg-Gehtman; Emmanuel Vidor; Philippe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Preparation and immunogenicity of an ina

Preparation and immunogenicity of an inactivated hepatitis A vaccine

✍ V. Pellegrini; N. Fineschi; G. Matteucci; I. Marsili; L. Nencioni; M. Puddu; H. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Long-term immunogenicity and safety of a

Long-term immunogenicity and safety of an inactivated hepatitis A vaccine in haemophilic patients

✍ PIETRO DENTICO; NICOLA CIAVARELLA; FRANCESCO A. SCARAGGI; MARIO SCHIAVONI; ANNA 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers

✍ G. Wiedermann; F. Ambrosch; H. Kollaritsch; H. Hofmann; Ch. Kunz; E. D'Hondt; A. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Long-term immunogenicity of an inactivat

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine

✍ P.A. Bovier; J. Bock; L. Loutan; T. Farinelli; R. Glueck; C. Herzog 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract The aim of this study was to predict the long‐term protection induced after immunisation with inactivated, aluminium‐free virosome hepatitis A vaccine. The study population consisted of adult volunteers enrolled in four different clinical trials. Lower 95% confidence interval limits and

Safety and Immunogenicity of a High–Pote

Safety and Immunogenicity of a High–Potency Inactivated Hepatitis A Vaccine

✍ Pierre Van Damme; Stefan Thoelen; Myrjam Cramm; André Meheus 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB